Research services provider Domainex has secured a new, fully fitted, three-storey building in Unity Campus in Cambridgeshire, UK.
Domainex first moved to Unity Campus in January 2022, taking 7,000 sq ft of laboratory space at Iconix 2 to provide a dedicated facility for its biology department and freeing up space at its closely located Chesterford Research Park site.
Established in 2001 as a spin-out from University College London, Birkbeck College and the Institute of Cancer Research, Domainex has been supported throughout its development by a consortium of UCL Business, Longbow Capital, Bury Fitzwilliam Lay, Juno Capital and a syndicate of other private investors.
At over 24,000 sq ft, Building A2 provides a significantly increased floor area for Domainex’s biology department compared to Iconix 2. This allows space for both new instrumentation and staff, which will be essential for the company to continue to expand.
Dr Tom Mander, CEO of Domainex, said: “With the backing of our shareholders and the Board of Domainex, we are embarking on this significant expansion and funding it through our existing reserves. We look forward to the future with optimism and are poised to remain at the forefront of new medicines research for the ultimate benefit of patients.”
Image shows: Nicholas Bewes, CEO, Howard Group and Tom Mander, CEO, Domainex, inside The Works Building, Unity Campus.